The B And T Lymphocyte Attenuator pipeline drugs market research report outlays comprehensive information on the B And T Lymphocyte Attenuator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the B And T Lymphocyte Attenuator pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Immunology, Oncology, and Dermatology which include the indications Graft Versus Host Disease (GVHD), Autoimmune Disorders, Solid Tumor, Renal Cell Carcinoma, and Atopic Dermatitis (Atopic Eczema). It also reviews key players involved in B And T Lymphocyte Attenuator targeted therapeutics development with respective active and dormant or discontinued products.
The B And T Lymphocyte Attenuator pipeline targets constitutes close to seven molecules. Out of which, approximately six molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, and Preclinical stages are 1, 1, 2, and 2 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
B And T Lymphocyte Attenuator overview
B- and T-lymphocyte Associated is a protein that in humans is encoded by a gene BTLA. It is also known as cluster of differentiation 272 or CD272 and belongs to the CD28 immunoglobulin superfamily (IgSF). It contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response.
For a complete picture of B And T Lymphocyte Attenuator’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.